Seoul, South Korea

Kyung-Il Chol


Average Co-Inventor Count = 31.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kyung-Il Chol: Innovator in Neurodegenerative Disease Treatment

Introduction

Kyung-Il Chol is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of neurodegenerative diseases through his innovative research and patent developments. His work focuses on creating novel compounds that can aid in the prevention and treatment of various brain diseases.

Latest Patents

Kyung-Il Chol holds a patent for "Benzoarylureido compounds, and composition for prevention or treatment of neurodegenerative brain disease containing the same." This patent introduces novel benzoarylureido compounds that are designed for the prevention and treatment of neurodegenerative brain diseases, including Alzheimer's disease, dementia, Parkinson's disease, and others. The implications of this research are profound, as it addresses critical health challenges faced by aging populations.

Career Highlights

Kyung-Il Chol is affiliated with the Korea Institute of Science and Technology, where he conducts his research. His dedication to advancing medical science is evident in his innovative approach to tackling complex health issues. With a focus on neurodegenerative diseases, he aims to improve the quality of life for individuals affected by these conditions.

Collaborations

Kyung-Il Chol has collaborated with esteemed colleagues, including Hoh-Gyu Hahn and Kee-Dal Nam. These partnerships enhance the research efforts and contribute to the development of effective treatments for neurodegenerative diseases.

Conclusion

Kyung-Il Chol's work in developing benzoarylureido compounds represents a significant advancement in the fight against neurodegenerative diseases. His contributions to medical science are invaluable, and his ongoing research holds promise for future breakthroughs in treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…